Patient Centricity — taking care of our most valuable asset!
.custom-column-left-text {
float: left;
width: 50%;
padding-right: 10px;
}
.custom-column-right-text {
float: right;
width: 45%;
text-align:center;
}
@media only screen and (max-width: 600px) {
.custom-column-left-text,
.custom-column-right-text,
.custom-column-flc-ebook-text {
float:none;
width:80%;
margin:0 auto;
}
}
“Patient centricity” is the process of designing a service or solution around the patient; more specifically, it is collectively defined as “Putting the patient fi
Because who Doesn’t Love a Quiz!
ISSUE NO. 2 — Revolutionizing Traditional Medicine With Cannabis-based Medicinal Products
Will Biosimilars Replace Biologics?
.custom-column-left-text {
float: left;
width: 50%;
padding-right: 10px;
}
.custom-column-right-text {
float: right;
width: 45%;
text-align:center;
}
@media only screen and (max-width: 600px) {
.custom-column-left-text,
.custom-column-right-text,
.custom-column-flc-ebook-text {
float:none;
width:80%;
margin:0 auto;
}
}
Biologic drugs came on the market with the production of
ISSUE NO. 1 — FDA Guidance Ensures New Drugs Are Studied for Their Potential to Impair Driving Ability
Development of an Affinity Capture - LC-MS/MS Assay for the Quantitation of Adalimumab in Human Plasma using BioBA Sample Preparation Kit
A Novel Strategy for the In-Process Stabilization of N-Oxide Metabolites in Hemolyzed Plasma Determined by LC-MS/MS
The Application of Research Grade MetabolitePilot™ Software for the Determination of Exenatide Catabolites Using HRAM With SWATH Acquisition
Stability Evaluation of Captopril in Human Blood by LC-MS/MS
Development of a Multi-Peptide Immunocapture – LC-MS/MS Assay for the Quantitation of a PEGylated Therapeutic in Rat and Dog Plasma